This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.

Close Message
NextPharmaJob.com for pharmaceutical industry jobs
Media Contacts
NextPharmaJob.com is dedicated to putting job seekers looking for pharmaceutical industry jobs in touch with recruiters and employers.
Browse Jobs Search Jobs

To receive a FREE weekly email alert of all the latest pharmaceutical industry jobs added to our database enter your email address below.

Submit | Tell me more...

Sister sites:
Our sister site Our sister site
Partner sites:

At Burntsky Limited we work with a number of third parties in order to maximise the reach of the jobs posted with us including but not limited to:

JooblePartner Jooble
UK Jobs
Science Jobs

Industry News
31 December 2020 14:30RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib
Preliminary data from the non-powered U.S. Phase 2 study of 40 hospitalized patients shows that orally-administered opaganib was safe, with no material safety differences between opaganib and control arms Consistent trends demonstrate greater impro

31 December 2020 14:30RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib
TEL AVIV, Israel and RALEIGH, N.C., Dec. 31, 2020 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that preliminary top-line data from its U.S. Phase 2 study

31 December 2020 13:01Hoth Therapeutics Announces Production of HT-001 for Cancer Treatment
NEW YORK, Dec. 31, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that it has signed a production agreement for both GLP and GMP materials associated with HT-001  with Tergus Pharma for its

31 December 2020 11:29ImmVira Announces Series C Financing with Leading Specialist Investors
SHENZHEN, China, Dec. 31, 2020 /PRNewswire/ -- ImmVira Group Company ("the Company"), a biotechnology platform dedicated to the development of oncolytic virus("OV") and vector type approaches to create more effective and safer therapies against can

30 December 2020 04:33Glenmark receives one ANDA approval and two tentative ANDA approvals - Tadalafil Gabapentin Enacarbil and Apremilast
Glenmark Pharmaceuticals receives ANDA final approval for Tadalafil Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg; and receives ANDA tentative approvals for Gabapentin Enacarbil Extended-Release Tablets, 300 mg and 600 mg and Apremilast Tablets, 10 mg, 20

30 December 2020 01:27WinHealth und Immedica schließen eine Vereinbarung, die WinHealth die Rechte an Ravicti® in China und mehreren anderen asiatisch-pazifischen Ländern einräumt
STOCKHOLM und HANGZHOU, China, 31. Dezember 2020 /PRNewswire/ -- Die Hongkong WinHealth Pharma Group Co., Ltd. und Immedica Pharma AB, geben heute bekannt, dass sie eine Vereinbarung abgeschlossen haben, im Rahmen derer WinHealth die exklusiven kom

30 December 2020 01:00WinHealth and Immedica enter agreement giving Winhealth rights to Ravicti® in China and several other Asia-Pacific countries
STOCKHOLM and HANGZHOU, China, Dec. 31, 2020 /PRNewswire/ -- Hongkong WinHealth Pharma Group CO., Ltd and Immedica Pharma AB, today announce that they have entered an agreement under which WinHealth gains the exclusive commercial rights to Ravicti®

30 December 2020 01:00WinHealth e Immedica llegan a un acuerdo para proporcionar a Winhealth los derechos de Ravicti®
-       WinHealth e Immedica llegan a un acuerdo para proporcionar a Winhealth los derechos de Ravicti® en China y en varios países de Asia-Pacífico ESTOCOLMO y HANGZHOU, China, 31 de diciembre de 2020 /PRNewswire/ -- Hongkong WinHealth Pharma Gr

30 December 2020 01:00WinHealth and Immedica enter agreement giving Winhealth rights to Ravicti® in China and several other Asia-Pacific countries
STOCKHOLM and HANGZHOU, China, Dec. 30, 2020 /PRNewswire/ -- Hongkong WinHealth Pharma Group CO., Ltd and Immedica Pharma AB, today announce that they have entered an agreement under which WinHealth gains the exclusive commercial rights to Ravicti®

30 December 2020 01:00WinHealth et Immedica concluent un accord donnant à Winhealth les droits sur Ravicti® en Chine et dans plusieurs autres pays d'Asie-Pacifique
STOCKHOLM et HANGZHOU, Chine, 31 décembre 2020 /PRNewswire/ -- Hongkong WinHealth Pharma Group CO., Ltd et Immedica Pharma AB annoncent aujourd'hui qu'ils ont conclu un accord selon lequel WinHealth obtient les droits commerciaux exclusifs sur Ravi

30 December 2020 00:35FDA In Brief: Certain Lots of Sportmix Pet Food Recalled for Potentially Fatal Levels of Aflatoxin
SILVER SPRING, Md., Dec. 30, 2020 /PRNewswire/ -- The following quote is attributed to Amber McCoig, D.V.M., M.P.H., deputy director of the FDA's Center for Veterinary Medicine (CVM) Division of Compliance:   "Although this pet food recall is still

30 December 2020 18:55Emmes erwirbt Neox s.r.o., ein Unternehmen für klinische Forschung mit Hauptsitz in der Tschechischen Republik
Transaktion erweitert die Biopharma-Aktivitäten und die europäische Präsenz von Emmes  ROCKVILLE, Maryland, 30. Dezember 2020 /PRNewswire/ -- Emmes, ein globales Full-Service-Unternehmen für klinische Forschung (CRO), welche die Förderung des öff

30 December 2020 15:00Emmes Acquires Neox s.r.o., a Clinical Research Organization Headquartered in the Czech Republic
ROCKVILLE, Md., Dec. 30, 2020 /PRNewswire/ -- Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that it has acquired Neox s.

30 December 2020 15:00Emmes Acquires Neox s.r.o., a Clinical Research Organization Headquartered in the Czech Republic
Transaction Expands Emmes' Biopharma Effort and European Presence ROCKVILLE, Md., Dec. 30, 2020 /PRNewswire/ -- Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopha

30 December 2020 15:00Emmes acquiert Neox s.r.o., un organisme de recherche clinique dont le siège se situe en République tchèque
La transaction accroît l'effort biopharmaceutique et la présence européenne d'Emmes  ROCKVILLE, Maryland, 30 décembre 2020 /PRNewswire/ -- Emmes, une organisation de recherche clinique (CRO) mondiale offrant une gamme complète de services et dont

30 December 2020 15:00Emmes adquiere Neox s.r.o., organización de investigación clínica con sede en la República Checa
La transacción amplía el esfuerzo biofarmacéutico de Emmes y su presencia en Europa ROCKVILLE, Md., 30 de diciembre de 2020 /PRNewswire/ -- Emmes, organización de investigación clínica (CRO) global y de servicio completo dedicada al apoyo del ava

30 December 2020 14:00Yuyu Pharma was recognized as "Family-Friendly Company" by the Ministry of Gender Equality and Family
SEOUL, South Korea, Dec. 30, 2020 /PRNewswire/ -- Yuyu Pharma(CEO Robert Wonsang Yu, KRX: 000220) received recognition from the Ministry of Gender Equality and Family for implementing family-friendly policies for their employees. This is the second

30 December 2020 13:45Wize Pharma and Cosmos Capital enter into Bid Implementation Agreement
HOD HASHARON, Israel, and SYDNEY, Dec. 30, 2020 /PRNewswire/ -- Wize Pharma, Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, and Cosmos Capital Limited, a leading digital infrastructu

30 December 2020 13:38LyGenesis Receives FDA Clearance to Begin Phase 2a Trial of its Cell Therapy for Patients with End Stage Liver Disease, and also Closes $11 Million Convertible Debt Financing
PITTSBURGH, Dec. 30, 2020 /PRNewswire/ -- LyGenesis, Inc., a biotechnology company developing cell therapies that enable organ regeneration, announced today that the U.S Food and Drug Administration (FDA) has cleared its Investigational New Drug (I

30 December 2020 13:00QYNAPSE Joins Decentralized Trials & Research Alliance (DTRA) To Democratize And Accelerate Clinical Trials
PARIS and BOSTON, Dec. 30, 2020 /PRNewswire/ -- QYNAPSE Inc. joins a historic alliance of fifty life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research. T
News last updated 21/04/2021 06:07:42
line graphic

Compatible with:

JobMate   Broadbean   Idibu

Site optimised for Internet Explorer 8+ / Firefox 3+
View a complete Jobs Listing




Credit cards image